# Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.

> **NCT04864873** · NA · UNKNOWN · sponsor: **Capital and Coast District Health board** · enrollment: 400 (estimated)

## Conditions studied

- Bacterial Infections

## Interventions

- **DIAGNOSTIC_TEST:** Metagenomic next generation sequencing using Oxford Nanopore
- **DIAGNOSTIC_TEST:** Standard microbiological diagnostic pathway

## Key facts

- **NCT ID:** NCT04864873
- **Lead sponsor:** Capital and Coast District Health board
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2022-05
- **Final completion:** 2022-05
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2021-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864873, "Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04864873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*